| 000 | 01836 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518080045.0 | ||
| 264 | 0 | _c20210209 | |
| 008 | 202102s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/clinem/dgz318 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKroiss, Matthias | |
| 245 | 0 | 0 |
_aObjective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _c05 2020 |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aAdrenocortical Carcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnilides _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aProgression-Free Survival |
| 650 | 0 | 4 |
_aPyridines _xtherapeutic use |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMegerle, Felix | |
| 700 | 1 | _aKurlbaum, Max | |
| 700 | 1 | _aZimmermann, Sebastian | |
| 700 | 1 | _aWendler, Julia | |
| 700 | 1 | _aJimenez, Camilo | |
| 700 | 1 | _aLapa, Constantin | |
| 700 | 1 | _aQuinkler, Marcus | |
| 700 | 1 | _aScherf-Clavel, Oliver | |
| 700 | 1 | _aHabra, Mouhammed Amir | |
| 700 | 1 | _aFassnacht, Martin | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 105 _gno. 5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/clinem/dgz318 _zAvailable from publisher's website |
| 999 |
_c30482441 _d30482441 |
||